
Sign up to save your podcasts
Or


In this week's episode, Susannah and Sarah look at how the pharmaceutical sector is faring after a whirlwind few years. Exploring weight loss treatments, AstraZeneca, Novo Nordisk, GSK, and falling healthy life expectancy, find out how all of this could affect your savings and investments.
This podcast isn’t personal advice. If you’re not sure what’s right for you seek advice. Investments rise and fall in value, so investors could make a loss.
Hosted on Acast. See acast.com/privacy for more information.
By Hargreaves LansdownIn this week's episode, Susannah and Sarah look at how the pharmaceutical sector is faring after a whirlwind few years. Exploring weight loss treatments, AstraZeneca, Novo Nordisk, GSK, and falling healthy life expectancy, find out how all of this could affect your savings and investments.
This podcast isn’t personal advice. If you’re not sure what’s right for you seek advice. Investments rise and fall in value, so investors could make a loss.
Hosted on Acast. See acast.com/privacy for more information.

56 Listeners

35 Listeners

15 Listeners

42 Listeners

87 Listeners

15 Listeners

15 Listeners

6 Listeners

12 Listeners

8 Listeners

4 Listeners

52 Listeners

10 Listeners

38 Listeners

3 Listeners